NCT01756365View on ClinicalTrials.gov

Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency

NARecruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Limbal Stem Cell Deficiency
Interventions
PROCEDURE

Surgical transplantation of ACCE

The culture of corneal epithelium strives to produce a reconstructed tissue with the therapeutical aim of treatment of limbal stem cell deficiency.

Trial Locations (4)

M5T 2S8

RECRUITING

University Health Network - Toronto Western Hospital, Toronto

H1T 2M4

RECRUITING

CIUSSS de l'Est de l'île de Montréal, Montreal

Unknown

RECRUITING

McGill University Health Centre; Centre de Médecine Innovatrice/Centre for Innovative Medicine, Montreal

G1S 4L8

RECRUITING

Centre universitaire d'Ophtalmologie CHU de Québec - HSS, Québec

All Listed Sponsors
lead

CHU de Quebec-Universite Laval

OTHER

NCT01756365 - Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency | Biotech Hunter | Biotech Hunter